B7-H1 and B7-H4 expression in colorectal carcinoma: Correlation with tumor FOXP3+ regulatory T-cell infiltration

Acta Histochemica

Volumn 116, Issue 7, 2014, Pages 1163-1168

  Zhao, Li wei ^a,b   Li, Chun ^a   Zhang, Rui lan ^a   Xue, Hao gang ^a   Zhang, Fu xi ^a   Zhang, Fan ^a   Gai, Xiao dong ^a  

^a BEIHUA UNIVERSITY   (China)

^b JILIN MEDICAL COLLEGE   (China)

Author keywords

B7 H1; B7 H4; Colorectal cancer; Immunohistochemistry; Regulatory T cells

Indexed keywords

PROGRAMMED DEATH 1 LIGAND 1; TRANSCRIPTION FACTOR FOXP3; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1; CD274 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; TUMOR MARKER; VTCN1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION COEFFICIENT; EXANTHEMA SUBITUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; COLORECTAL TUMOR; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; TUMOR ESCAPE;

ADULT; AGED; ANTIGENS, CD274; COLORECTAL NEOPLASMS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MALE; MIDDLE AGED; T-LYMPHOCYTES, REGULATORY; TUMOR ESCAPE; TUMOR MARKERS, BIOLOGICAL; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84924049163     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2014.06.003     Document Type: Article

References (37)

1. Beyer M., Schultze J.L. Regulatory T cells: major players in the tumor microenvironment. Curr Pharm Des 2009, 15:1879-1892.
2. Carreno B.M., Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002, 20:29-53.
3. Choi I.H., Zhu G., Sica G.L., Strome S.E., Cheville J.C., Lau J.S., et al. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 2003, 171:4650-4654.
4. Dong H., Strome S.E., Salomao D.R., Tamura H., Hirano F., Flies D.B., et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002, 8:793-800.
5. Flies D.B., Chen L. The new B7s: playing a pivotal role in tumor immunity. J Immunother 2007, 30:251-260.
6. + regulatory T cells. Nat Immunol 2003, 4:330-336.
7. Francisco L.M., Salinas V.H., Brown K.E., Vanguri V.K., Freeman G.J., Kuchroo V.K., et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J Exp Med 2009, 206:3015-3029.
8. + regulatory T cell development in human colorectal cancer and tumor draining lymph node. Pathol Res Pract 2013, 209:774-778.
9. Ghebeh H., Tulbah A., Mohammed S., Elkum N., Bin Amer S.M., Al-Tweigeri T., et al. Expression of B7-H1 in breast cancer patients is strongly associated with high proliferative Ki-67-expressing tumor cells. Int J Cancer 2007, 121:751-758.
10. + T lymphocytes are prognostic factors of human ovarian cancer. Proc Natl Acad Sci U S A 2007, 104:3360-3365.
11. Herszényi L., Tulassay Z. Epidemiology of gastrointestinal and liver tumors. Eur Rev Med Pharmacol Sci 2010, 14:249-258.
12. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
13. +T cells affect the prognosis of hepatocellular carcinoma patients. Digestion 2012, 86:329-337.
14. Ichikawa M., Chen L. Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms. Front Biosci 2005, 10:2856-2860.
15. Janakiram M., Abadi Y.M., Sparano J.A., Zang X. T cell coinhibition and immunotherapy in human breast cancer. Discov Med 2012, 14:229-236.
16. + regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer. Gastric Cancer 2012, 15:144-153.
17. + T regulatory cells. Nat Immunol 2003, 4:337-342.
18. Khoury S.J., Sayegh M.H. The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 2004, 20:529-538.
19. Koudougou C., Bonneville M., Matysiak-Budnik T., Touchefeu Y. Review article: antitumoural immunity in colorectal cancer-current and potential future implications in clinical practice. Aliment Pharmacol Ther 2013, 38:3-15.
20. Kristensen N.N., Schmidt E.G., Rasmussen S., Balk-Møller E., Claesson M.H. B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells. Immunopharmacol Immunotoxicol 2013, 35:505-513.
21. Kryczek I., Wei S., Zhu G., Myers L., Mottram P., Cheng P., et al. Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. Cancer Res 2007, 67:8900-8905.
22. + T cells negatively regulates the activation of immune responses in aged animals. J Immunol 2010, 184:5466-5474.
23. Ni X.Y., Sui H.X., Liu Y., Ke S.Z., Wang Y.N., Gao F.G. TGF-β of lung cancer microenvironment upregulates B7H1 and GITRL expression in dendritic cells and is associated with regulatory T cell generation. Oncol Rep 2012, 28:615-621.
24. + regulatory T cells in tumor immunity. Curr Top Microbiol Immunol 2005, 293:287-302.
25. Park J.J., Omiya R., Matsumura Y., Sakoda Y., Kuramasu A., Augustine M.M., et al. B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance. Blood 2010, 116:1291-1298.
26. Salceda S., Tang T., Kmet M., Munteanu A., Ghosh M., Macina R., et al. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation. Exp Cell Res 2005, 306:128-141.
27. Sica G.L., Choi I.H., Zhu G., Tamada K., Wang S.D., Tamura H., et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003, 18:849-861.
28. Sun Y., Wang Y., Zhao J., Gu M., Giscombe R., Lefvert A.K., et al. B7-H3 and B7-H4 expression in non-small-cell lung cancer. Lung Cancer 2006, 53:143-151.
29. Thompson R.H., Dong H., Kwon E.D. Implications of B7-H1 expression in clear cell carcinoma of the kidney for prognostication and therapy. Clin Cancer Res 2007, 13:709s-715s.
30. Tringler B., Liu W., Corral L., Torkko K.C., Enomoto T., Davidson S., et al. B7-H4 overexpression in ovarian tumors. Gynecol Oncol 2006, 100:44-52.
31. + regulatory T cells. Proc Natl Acad Sci U S A 2008, 105:9331-9336.
32. Wang X., Hao J., Metzger D.L., Ao Z., Chen L., Ou D., et al. B7-H4 treatment of T cells inhibits ERK, JNK, p38, and AKT activation. PLOS ONE 2012, 7:e28232.
33. + T-cell proliferation by augmenting IFN-gamma-induced nitric oxide production. J Immunol 2005, 175:1586-1592.
34. Yuan X.L., Chen L., Li M.X., Dong P., Xue J., Wang J., et al. Elevated expression of Foxp3 in tumor-infltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner. Clin Immunol 2010, 134:277-288.
35. Zang X., Thompson R.H., Al-Ahmadie H.A., Serio A.M., Reuter V.E., Eastham J.A., et al. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome. Proc Natl Acad Sci U S A 2007, 104:19458-19463.
36. Zheng X., Li X.D., Wu C.P., Lu B.F., Jiang J.T. Expression of costimulatory molecule B7-H4 in human malignant tumors. Onkologie 2012, 35:700-705.
37. Zou W., Chen L. Inhibitory B7-family molecules in the tumour microenvironment. Nat Rev Immunol 2008, 8:467-477.